Effects of GPER-1 on Diabetic Retinopathy
Author Information
Author(s): Beyoğlu Abdullah, Kurutaş Ergül Belge, Karaküçük Yalçın, Çömez Ayşegül, Meşen Ali
Primary Institution: Sutcu Imam University
Hypothesis
This study aimed to determine the effect of serum G receptor-mediated protein-1 levels on the development of retinopathy in patients with diabetes in comparison with healthy individuals.
Conclusion
Increased levels of serum G receptor-mediated protein-1 may help prevent diabetic retinopathy.
Supporting Evidence
- Serum G receptor-mediated protein-1 levels were highest in the diabetic retinopathy group.
- A significant difference was found among all groups in terms of serum G receptor-mediated protein-1, oxidant/antioxidant, and estradiol levels.
- Serum G receptor-mediated protein-1 and oxidant levels were positively correlated.
Takeaway
The study looked at how a protein called GPER-1 affects eye problems in people with diabetes compared to healthy people, finding that higher levels of this protein might help protect against these problems.
Methodology
The study enrolled patients with diabetic retinopathy, patients without diabetic retinopathy, and healthy individuals, analyzing various serum levels and performing post-hoc analysis.
Limitations
The study did not include premenopausal women to minimize hormonal differences and did not measure serum oxidative stress molecules with GPER-1 agonist agents.
Participant Demographics
Groups included 40 patients each with diabetic retinopathy, without diabetic retinopathy, and healthy individuals, with no significant differences in age or sex.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website